SSC
RDY icon

Syverson Strege & Co’s Dr. Reddy's Laboratories RDY Stock Holding History

Syverson Strege & Co’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-545
Closed -$6.21K – 488
2023
Q1 		$6.21K Buy
+545
New +$5.88K ﹤0.01% 305

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Syverson Strege & Co's RDY Position: Q2 2023 in Review

Syverson Strege & Co sold out of Dr. Reddy's Laboratories (RDY) in Q2 2023, closing a stake of 545 shares — an estimated $6.21K sold.

Syverson Strege & Co first reported a position in RDY in Q1 2023 and held it in 1 quarter. The position peaked at $6.21K in Q1 2023. 193 funds tracked by Wall St. Rank hold RDY as of Q2 2023.

  • Syverson Strege & Co reported no remaining Dr. Reddy's Laboratories position as of Q2 2023 after selling out during the quarter.
  • Syverson Strege & Co sold 545 Dr. Reddy's Laboratories shares in Q2 2023, an estimated $6.21K.
  • Syverson Strege & Co first reported a position in Dr. Reddy's Laboratories in Q1 2023 and held it in 1 quarter.
  • Syverson Strege & Co's Dr. Reddy's Laboratories position peaked at $6.21K in Q1 2023.
  • 193 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2023.

Based on Syverson Strege & Co's 13F filing for Q2 2023, filed 4 Aug 2023.